Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Lin Y.-W.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 55 到 74 筆資料,總共 74 筆
< 上一頁
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2018
Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced buccal cancer: Initial masticator space involvement is the key factor of recurrence
Lin Y.-W.; YA-FANG CHEN
; Yang C.-C.; Ho C.-H.; Wu T.-C.; Yen C.-Y.; Lin L.-C.; Lee S.P.; Lee C.-C.; Tai M.-H.
Head and Neck
3
3
2013
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells
Chen R.-S.; JEN-CHANG KO
; Chiu H.-C.; Wo T.-Y.; Huang Y.-J.; Tseng S.-C.; Chen H.-J.; Huang Y.-C.; Jian Y.-J.; Lee W.-T.; Lin Y.-W.
Naunyn-Schmiedeberg's Archives of Pharmacology
9
9
2009
Perceptions of general education on occupational health and safety among college students in Taiwan
Tong Y.-H.; Lin Y.-W.; CHIH-CHIEH CHEN
; Lin J.-M.
Journal of Occupational and Environmental Hygiene
3
2
2015
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells
JEN-CHANG KO
; Syu J.-J.; Chen J.-C.; Wang T.-J.; Chang P.-Y.; Chen C.-Y.; Jian Y.-T.; Jian Y.-J.; Lin Y.-W.
Basic and Clinical Pharmacology and Toxicology
22
15
2009
Role of acid-sensing ion channel 3 in sub-acute-phase inflammation
Yen Y.-T.; Tu P.-H.; Chen C.-J.; Lin Y.-W.; SUNG-TSANG HSIEH
; Chen C.-C.
Molecular Pain
92
87
2009
The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells
JEN-CHUNG KO
; Wang L.-H.; Jhan J.-Y.; Ciou S.-C.; Hong J.-H.; Lin S.-T.; Lin Y.-W.
Lung Cancer
9
9
2006
The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: A novel mechanism involved in vascular inflammation
Lin F.-Y.; Chen Y.-H.; Lin Y.-W.; Tsai J.-S.; Chen J.-W.; Wang H.-J.; YUH-LIEN CHEN
; Li C.-Y.; Lin S.-J.
Arteriosclerosis, Thrombosis, and Vascular Biology
70
69
2012
Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization
Liu J.-T.; YUH-LIEN CHEN
; Chen W.-C.; Chen H.-Y.; Lin Y.-W.; SHU-HUEI WANG
; Man K.-M.; Wan H.-M.; Yin W.-H.; Liu P.-L.; Chen Y.-H.
Journal of Biomedicine and Biotechnology
35
50
2008
Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
JEN-CHUNG KO
; Hong J.-H.; Wang L.-H.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Jheng M.-Y.; Lin Y.-W.
Molecular Cancer Therapeutics
38
35
2008
The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer
JEN-CHUNG KO
; Hong J.-H.; Wang L.-H.; Lin Y.-W.
Experimental Cell Research
14
14
2009
Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Ciou S.-C.; Jhan J.-Y.; Cheng C.-M.; Su Y.-J.; Chuang S.-M.; Lin S.-T.; Chang C.-C.; Lin Y.-W.
Molecular Cancer Research
45
40
2016
Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression
JEN-CHUNG KO
; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
Biochemical Pharmacology
10
10
2020
Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer
Lin Y.-W.; Wen Y.-C.; Chu C.-Y.; Tung M.-C.; Yang Y.-C.; KUO-TAI HUA
; Pan K.-F.; Hsiao M.; Lee W.-J.; Chien M.-H.
Cell Death and Disease
15
10
2010
Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells
JEN-CHUNG KO
; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Lin Y.-W.
Biochemical Pharmacology
71
62
2014
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells
JEN-CHANG KO
; Chiu H.-C.; Syu J.-J.; Jian Y.-J.; Chen C.-Y.; Jian Y.-T.; Huang Y.-J.; Wo T.-Y.; Lin Y.-W.
Biochemical Pharmacology
26
25
1998
Telomerase activity and telomere length in human hepatocellular carcinoma
GUAN-TARN HUANG
; Lee, Hsuan-Shu
; CHIEN-HUNG CHEN
; Chiou L.-L.; Lin Y.-W.; Lee, Cha-Ze
; DING-SHINN CHEN
; JIN-CHUAN SHEU
European Journal of Cancer
25
22
2017
Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts
Chien, M.-H.; Lee T.-H.; Lee W.-J.; Yeh Y.-H.; TSAI-KUN LI
; Wang P.-C.; Chen J.-J.; Chow J.-M.; Lin Y.-W.; Hsiao M.; Wang S.-W.; TZONG-HUEI LEE et al.
Cancer Letters
14
12
2006
A two-step protocol for the detection of rearrangements at the AZFc region on the human Y chromosome
Lin Y.-W.; CHIA-LIN HSU
; Yen P.H.
Molecular Human Reproduction
21
19
2011
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
JEN-CHUNG KO
; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W.
Journal of Pharmacology and Experimental Therapeutics
19
20
2020
Utilization of healthcare and psychotropic medication in elderly and non-elderly people with first self-poisoning episodes: A nationwide population-based cohort study
CHIA-YI WU
; CHIN-KUO CHANG
; FEI-YUAN HSIAO
; Lin Y.-W.; Wu S.-I.; Kao K.-L.
European Journal of Psychiatry
0
0